Rare Disease Patients Face Barriers in Access and Care
People with Friedreich's ataxia face debilitating symptoms, too few medical specialists and too many health insurance barriers, physicians explain in new policy paper
WASHINGTON, Feb. 5, 2025 /PRNewswire/ -- An FDA-approved medication can now treat Friedreich's ataxia, but health plan barriers and formulary exclusions keep many patients from receiving it.
In a white paper by the Alliance for Patient Access and the Friedreich's Ataxia Research Alliance, titled " Friedreich's Ataxia: A Rare Condition Facing Common Access Challenges,' physician authors outline the disease's debilitating symptoms as well as the treatment challenges that accompany it. The rare genetic condition often begins in childhood and affects the brain, heart and neurological system.
After years with no dedicated treatment option, the FDA approved omaveloxolone in 2023. Hailed as 'an exciting step forward for the FA community,' the medication remains out of reach for many patients. Some health plans have excluded the new drug from their formulary. Others cover it but only with onerous prior authorization and step therapy protocols, which delay care for patients already struggling with the disease's symptoms.
These barriers compound existing challenges. Finding a specialist or clinician who can diagnose Friedreich's ataxia, given its rarity, remains difficult. Clinician knowledge gaps and transportation challenges often mean delayed diagnosis or misdiagnosis.
'Due to the progressive nature of Friedreich's ataxia, people living with the condition cannot afford delays in access to knowledgeable healthcare professionals or treatment,' says Kellyn Madden, patient engagement manager for the Friedreich's Ataxia Research Alliance. 'The FA community has partnered for many years with researchers to bring treatments forward. This white paper marks a significant step in raising awareness and advocating for policies that facilitate access to this care.'
The white paper proposes several potential policy solutions, including:
Limits on health plan utilization management
Expanded coverage for telehealth
Support for innovation and more opportunities for children to participate in clinical trials
STATEMENT FROM JOSIE COOPER, EXECUTIVE DIRECTOR OF THE ALLIANCE FOR PATIENT ACCESS: 'Patients with Friedreich's ataxia deserve access to innovative treatments and patient-centered care. With health plan barriers negatively impacting these patients' physical and mental health, policy change is critical.'
The Alliance for Patient Access is a network of policy-minded health care providers who advocate for patient-centered care.
The Friedreich's Ataxia Research Alliance (FARA) is a national, public, 501(c)(3), nonprofit, organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's ataxia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Rocketseed launches essential email signature guide for healthcare organizations
New resource helps healthcare providers improve branded communication, ensure HIPAA compliance, and boost patient engagement through smart email signature management. CHARLOTTE, N.C., June 6, 2025 /PRNewswire/ -- Rocketseed, a global leader in business email signature management and marketing, has released a new comprehensive resource, Healthcare Email Signature Management: An Essential Guide. Specifically developed for hospitals, clinics, and other healthcare providers, the guide shows how professionally managed email signatures can support compliance, strengthen branding, and enhance communication across the sector, increasing engagement amongst both patients and staff. With healthcare professionals under increasing pressure to meet data protection regulations like HIPAA, maintain patient trust, promote new treatments and key services, and strengthen workplace inclusivity, this guide offers practical, actionable advice for IT leaders, marketers, and frontline staff alike to achieve these goals - all through everyday email. Helping Healthcare Providers Stay Professional, Compliant and ConnectedThe guide outlines how to design, manage and run marketing campaigns with email signatures and banners to meet specific healthcare industry challenges and maximize results. Key topics include: Best practice email signature design tips and examples for healthcare professionals, including doctors and administrators. Benefits of centralized signature management, including guaranteed brand consistency, and saving IT time through automating all staff signature updates. Importance of using HIPAA (plus ISO27001, GDPR and POPIA) compliant email signature management software to ensure patient confidentiality and data protection. Use of targeted, interactive email banners for promoting seasonal health campaigns, patient education, and new treatments and services - all illustrated with examples. Internal email banner use for HR, training, and strengthening workplace culture. Role of robust analytics and real-time reporting in measuring email signature and banner success and ROI. Rocketseed's platform is HIPAA compliant, works across all email clients (including Microsoft 365 and Google Workspace) and devices, and helps healthcare IT teams save hundreds of hours through automation and user directory synchronization. "In today's highly-regulated healthcare environment, clear and compliant communication is essential," says Damian Hamp-Adams, North America CEO at Rocketseed. "Our guide shows how email signatures - when centrally managed and professionally designed - can do more than meet HIPAA requirements. They become a trusted communication tool across the entire organization." Driving Engagement Through Data and DesignThe guide also explores how analytics and real-time reporting can optimize engagement. Healthcare organizations can track all recipient interactions with their email banners and signature content, enabling smarter campaign decisions, such as refining designs and optimizing targeting, to generate greater return on their communication efforts. "Our goal is to help healthcare providers meet compliance needs while turning every email into a powerful communication channel," adds Damian. "This guide shows that with the right tools, even email signatures can play a vital role in delivering better patient care and stronger internal communication." This new release joins Rocketseed's growing library of industry-focused resources, including essential guides for hotels & hospitality, transportation & logistics, insurance, pharmaceutical and construction industries - each tailored to the unique compliance, branding, and communication needs of their sectors. About Rocketseed Rocketseed is a leading provider of email signature management and marketing solutions, used and trusted by businesses worldwide. With tools for centralized signature control, automated updates, targeted banner campaigns, and robust analytics, Rocketseed helps organizations maintain brand consistency, drive engagement, and ensure compliance — all through their everyday email. Learn more at Jennifer 547354 View original content to download multimedia: SOURCE Rocketseed (United States) Inc
Medscape
an hour ago
- Medscape
Medscape at 30: Three Decades of Amazing Breakthroughs
Medscape turns 30 in 2025. As part of the Medscape 2050 project speculating on what the field will look like 25 years from now, we're looking back at medical history as told through Medscape news coverage. A walk down memory lane, for sure, but also a celebration of the breakthroughs, headlines, and reporting that helped define medicine since 1995. July 5, 1996: Dolly the Sheep Cloned The birth of the first cloned animal led to some interesting cloning coverage over the years, whether from claims of a cloned human baby, ethical concerns surrounding human cloning, and advances in animal cloning as more than just a curiosity: Single Genetic Difference May Make Humans Easier to Clone Knockout Pigs Heralded as Future Organ Source FDA: Meat of Cloned Animals Safe to Eat 1998: Discovery of Human Embryonic Stem Cells A groundbreaking and polarizing discovery. Just over a year later, Medscape would look at the fallout, and advances would attempt to eliminate ethical concerns by tricking mouse and human cells to exhibit all the traits of embryonic stem cells. Coverage would span many conditions over the years: Is New Stem Cell Research Major Step Toward Diabetes Cure? Stem Cell Therapy Among Hot Topics at AAO 2017 Promising New Data on Stem Cell Therapy for Parkinson's 1997: da Vinci Robotic Surgical System Begins Development Minimally invasive robotic surgery via the da Vinci system was approved by the FDA in 2000, and by 2011, it was in use in more than 2000 hospitals around the world. Between 2011 and 2012, however, adverse event reports rose 34%, prompting this detailed Medscape slideshow, Robotic Surgery: Too Much, Too Soon? 2000: First Draft of the Human Genome Announced It wasn't perfect, it had gaps and wasn't fully understood, but the turn of the century marked the first map of the human genome, paving the way for what we now see as precision and personalized medicine. In 2020, Medscape commissioned a thorough charting of the genome over its first 20 years to see what grew from that first announcement. Early 2000s: Rise of Direct-to-Consumer (DTC) Genetic Testing (eg, 23andMe) Inexpensive genetic testing led to the advent of offering tests to consumers, and the most famous purveyor, 23andMe, debuted in 2006. This marked a shift in how people access and interpret genetic data — and raised concerns. It's been a bumpy ride: Ethical Considerations in DTC Genetic Testing 23andMe Relaunches Lower-Risk DTC Genetic Tests FDA OK's First DTC Genetic Risk Tests 23andMe Notifies Customers of Data Breach Into Its 'DNA Relatives' Feature 23andMe's Business Woes Raise Genetic Data Privacy Concerns: Ethicist 2009: Electronic Health Record (EHR) Adoption Incentivized by HITECH Act EHRs, now ubiquitous, started slow in 2009, with one report estimating adoption in US hospitals at less than 2%. All that changed of course, with Medscape eventually releasing annual reports on physicians and EHRs. And in 2024, we even asked if physicians should be compensated for their time using EHRs. Don't Get Too Hung Up on 'Meaningful Use' in an EHR EHR Adoption Grows Rapidly in Office-Based Physician Groups 2012: CRISPR-Cas9 Gene Editing Discovered 2016: First CRISPR Clinical Trial in Humans Gene editing, and the ethical arguments that went with it, took the medical world by storm a little over a decade ago. Medscape has been covering its potential therapeutic (and controversial) applications ever since including the 2018 birth of 'gene-edited babies' in China. 5 Things to Know About CRISPR New CRISPR Tools More Precise, but Targeting Mishaps a Worry CRISPR Gene Editing in Limelight at ASHG 2016 Bioethicist: History Tells Us CRISPR Fears Are Overblown 2016: Semaglutide Shows Superior Glucose Control and Weight Loss in SUSTAIN-6 Trials The hype begins. Not only shown effective for glucose control, semaglutide also demonstrated marked cardiovascular risk reduction in 2016. While that was nearly 10 years ago, it feels like we haven't had a day without GLP-1 news since. Oral GLP-1 Agonists Could Be Game Changers for Obesity Treating Obesity: Will New Miracle Drugs End the Crisis? GLP-1s Treat and Even Reverse Some Forms of Liver Disease GLP-1 Agonists Reduce Recurrent Atrial Fibrillation July-October 2017: CAR T-Cell Therapy Approved for Leukemia The FDA approved tisagenlecleucel-T (Kymriah, Novartis) and soon after a xicabtagene ciloleucel (Yescarta, Kite Pharma), the first two CAR T-cell therapies in 2017, opening the door for personalized cancer treatment and further progress beyond treating blood cancers. CARs Motor Through Leukemia, Part 2: 'Landscape Changing' CAR T Cells and Beyond: Breakthroughs and Challenges Ahead Outpatient CAR T: Safe, Effective, Accessible Next-Gen CAR T-Cell Therapy: Expanding Beyond Blood Cancers December 2020: mRNA Vaccines Approved After effectiveness of the Pfizer and Moderna COVID vaccines was documented, the FDA granted emergency use of both vaccines within a week of each other. This opened the door for further mRNA usage, including potential cancer vaccines. 4 Things to Know About Moderna's mRNA Cancer Vaccine New mRNA Vaccines in Development for Cancer and Infections 'Encouraging' Early Data for mRNA Vaccine in Glioblastoma New mRNA Vaccine May Shield Against C difficile Infections 2023: FDA Approvals in Medical Artificial Intelligence (AI), Especially Diagnostics, Increase While AI was not invented in 2023, that year became a tipping point in everything AI — from diagnostics to drug development to medical scribes, inspiring the first Medscape Physicians and AI Report, done annually since. A sampling of the flood of Medscape coverage: Minding the Machine: Assessing the Case for AI Regulations in Healthcare Harnessing FDA-Approved AI Technologies in Your Medical Practice The Protein Problem: The Unsolved Mystery of AI Drug Dev This Bill Could Make It Legal for AI to Prescribe Medicine AI vs Physicians in 2050: Happy Future or No Future?
New York Times
an hour ago
- New York Times
Live Updates: In Chaotic Economy, Hiring Remained Steady in May
Matt Minich, who was fired from his job with the Food and Drug Administration in February, was one of thousands swept up in the mass layoffs of probationary workers at the beginning of President Trump's second administration. After Matt Minich was fired from his job with the Food and Drug Administration in February, he did what many scientists have done for years after leaving public service. He looked for a position with a university. Mr. Minich, 38, was one of thousands swept up in the mass layoffs of probationary workers at the beginning of President Trump's second administration. The shock of those early moves heralded more upheaval to come as the Department of Government Efficiency, led by the tech billionaire Elon Musk, raced through agency after agency, slashing staff, freezing spending and ripping up government contracts. In March, about 45 minutes after Mr. Minich accepted a job as a scientist in the University of Wisconsin School of Medicine and Public Health, the program lost its federal grant funding. Mr. Minich, who had worked on reducing the negative health impacts of tobacco use, observed that he had the special honor of 'being DOGE-ed twice.' 'I'm doubly not needed by the federal government,' he said in an interview. He is still hunting for work. And like hundreds of thousands of other former civil servants forced into an increasingly crowded job market, he is finding that drastic cuts to grants and contracts in academia, consulting and direct services mean even fewer opportunities are available. Some states that were hiring, another avenue for former federal government employees, have pulled back. So, too, have the private contractors typically seen as a landing place. The situation is expected to worsen as more layoffs are announced, voluntary departures mount and workers who were placed on administrative leave see the clock run out. Image More than 700 people attended a recent resource fair in Arlington, Va., to receive free consultation, professional headshots and workshops. Credit... Maansi Srivastava for The New York Times With Mr. Musk's time in Washington now done, a fuller picture of just how completely he and Mr. Trump have upended the role of government is coming into view. Federal tax dollars underpin entire professions, directly and indirectly, and the cuts led by Mr. Musk's operation have left some workers with nowhere to go. In Washington, D.C., and the surrounding area, the disruption has the hallmarks of the collapse of an industrial cluster, not unlike the disappearance of manufacturing jobs in the upper Midwest during the 2000s. Except this time, it is moving at lightning speed. In January, just as Mr. Trump was taking office, the civilian federal work force across the country had reached a post-World War II peak of 2.3 million, not including the Postal Service. Few agencies have publicly stated how many people have been fired or voluntarily resigned, but a rough count shows that federal agencies have lost some 135,000 to firings and voluntary resignation, with another 150,000 in planned reductions. Contracted and grant-funded workers — which the Federal Reserve Bank of Atlanta estimated to be as many as 4.6 million people — are harder to track in official data. The first contractor layoffs began in February with organizations that received funding from the U.S. Agency for International Development, like Chemonics and FHI360. As more grants and contracts that were under review across government are terminated, job cuts have gained steam. Booz Allen Hamilton, the sprawling consulting firm based in Northern Virginia that gets 98 percent of its revenue from the federal government, announced that it was cutting 7 percent of its 36,000-person staff. Even providers of Head Start, the low-income preschool program, have issued layoff notices because funding has been in doubt. While the national labor market remains stable, job loss is starting to become notable in the capital region. Unemployment rates in the District of Columbia and most of its surrounding counties have been on the rise since December. The number of people receiving unemployment insurance has been elevated in Virginia and D.C. over the past several months. Job postings in Washington have dropped across the board, according to the hiring platform Indeed, including in opportunities for administrative assistance, human resources and accounting. Local government agencies around Washington are hosting dozens of hiring events, and most of them are packed. Elaine Chalmers of Woodbridge, Va., was among 750 people who attended a recent resource fair in Arlington, Va., just outside Washington. The event offered free consultation for updating résumés, as well as professional headshots and workshops, including one on managing personal finances during a transition in employment. Image Elaine Chalmers of Woodbridge, Va., resigned from her role at the Agriculture Department to escape the stress and uncertainty created by new mandates. Credit... Maansi Srivastava for The New York Times It was the fourth one she attended in the month since she left the Agriculture Department, where she had worked for 20 years, most recently in the division that ensured equal access to grants for rural communities. She resigned to escape the stress and uncertainty created by new mandates, such as erasing words like 'equity' and 'diversity' from department communications. 'It just became almost a character question for myself,' said Ms. Chalmers, 53. 'I couldn't honorably stay.' Like many of the federal workers who chose to take a deferred resignation or early retirement, one of the tools the administration has used to shrink the work force, she is on leave and will be paid through September. It is a relief, she said, because she is the sole caregiver for her mother and 15-year-old son. But the prospects do not look good. Ms. Chalmers said she expected to have to take a pay cut. She said she applied for more than 100 jobs in the week before the job fair and received several automated emails informing her that she did not get the position. For many government workers, career transitions can be especially daunting because their jobs are often extremely specific, performing functions that do not exist in the private sector. 'For a lot of them, it's almost like starting from scratch,' said Laura Moreno-Davis, a spokeswoman for WorkSource Montgomery, the work force agency for Montgomery County, Md., just outside D.C. 'If they really have a wealth of experience and knowledge, how can we best use that?' A new group formed by two former federal employees is trying to help people do that. 'How do you translate these skills that you've learned in the federal government that are so complex and seem to be so unique into something that can be communicated easily outside of the federal government?' said Julie Cerqueira, co-founder of the group, FedsForward. Ms. Cerqueira's partner, Karen Lee, said that people who worked in federal disaster recovery and resilience jobs, for example, had expertise that could easily transfer to private-sector work in contingency planning and supply chains. But it is not so simple for everyone. Chelsea Van Thof, 33, is a public health veterinarian who focused on diseases that spread from animals to humans, and humans to animals — a niche job even in government. A few weeks after the inauguration, the contract she worked under at the State Department was placed on hold for a 90-day review and ultimately terminated. Dr. Van Thof immediately lost her health insurance and took on a housemate to cover her rent. Image Chelsea Van Thof, a public health veterinarian, saw the contract she worked under at the State Department be placed on hold for a 90-day review and ultimately terminated a few weeks after President Trump's inauguration. Credit... Maansi Srivastava for The New York Times Plans for the future changed, too, as she had been counting on public-sector loan forgiveness to pay off her $250,000 in veterinary school debt, a prospect that now seems increasingly remote. She sometimes feels as though she is sending résumés into a void. 'I was just thankful when I got a rejection because it meant they saw my application,' she said. Like others in the science field, including Mr. Minich, she is looking for jobs outside the country. And in the meantime, she helped form a support group of about 80 wildlife protection conservationists who are in similar predicaments. People working on government contracts are hit especially hard because they are not eligible for the deferred resignation plans available to federal employees, and cannot look forward to their pensions. Todd Frank, of Westminster, Md., was given just a few minutes' notice before he was laid off as a technical writer on a contract with the Department of Homeland Security's science and technology directorate, helping get the appropriate gear out to military personnel in the field. Mr. Frank, 54, is now wrestling with whether to uproot his family to find a new job, which would come with steep trade-offs. His wife runs her own business — a licensed day care out of their home. His teenage sons do not want to leave their high school, he said. Lately, he is looking at the family's budget for where to make cuts. 'Not being able to buy a suit for prom sounds like rich people problems, but you don't want to turn around and tell your kid, 'You can't do this' or 'You can't do that,'' Mr. Frank said. Several states had advertised their eagerness to hire people laid off by the federal government in the early days of federal cuts. In March, Gov. Josh Shapiro of Pennsylvania said the state would give hiring preference to former federal workers. Since then, the state government has received more than 7,300 applications from people who said they had federal experience, his office said, and so far, state agencies have hired 120 of them. But state jobs have gotten a lot more popular in recent months. Since March, former and current federal employees have sent in nearly 700 applications, California's human resources office said. Some states are having their own budget problems, in part brought on by uncertainty around the continuation of federal funding. Alaska, Massachusetts, Indiana, Louisiana and New Hampshire have implemented hiring freezes. Public health agencies in Ohio and Alaska have laid people off as grants were canceled. And a broad swath of universities have also paused new hires, including the University of California system, the University of Pennsylvania, and Emory University in Georgia. With the Trump administration's firings of scientists and grant cancellations from agencies including the National Science Foundation and the National Institutes of Health, science and consulting have been hit especially hard, according to Indeed. Companies and nonprofits that helped evaluate whether federal programs were working, like American Institutes for Research, have let go up to a quarter of their payroll. Paro Sen, a research scientist in Cincinnati, was laid off in May along with most of the people in her office at the National Institute for Occupational Safety and Health. She worked on industrial hygiene, studying worker exposures that cause chronic health problems, and visited Washington in May with her union to talk to members of Congress about the need to restore these jobs to the federal government. 'This was my dream job that I have been ripped from,' she said in an interview. Ms. Sen and her colleagues work in such a specialized field that they are competing for very few available jobs, especially if they want to stay where they are. 'The job market right now is not amazing,' said Ms. Sen, 29. 'Cincinnati is not a very big city, and you've got, suddenly, some of the smartest people in this field all applying and competing for the exact same jobs at the same time.'
